The liver is the largest solid organ in the body and is critical for metabolic and immune
functions. However, little is known about the cells that make up the human liver and its immune …

The selection of liver transplant candidates with hepatocellular carcinoma (HCC) relies
mostly on tumor size and number. Instead of relying on these factors, we used poor tumor …

Importance Several factors are associated with increased hepatocellular carcinoma (HCC)
recurrence after liver transplantation (LT), but no reliable risk score has been established to …

Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Serum alpha‐fetoprotein (AFP) has been increasingly recognized as a marker for a poor
prognosis after liver transplantation (LT) for hepatocellular carcinoma (HCC). Many published …

The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide. Although
several advances have been made in the past decades to better understand this complex …

Objective: To measure and define the best achievable outcome after major hepatectomy.
Background: No reference values are available on outcomes after major hepatectomies. …

Mixed hepatocellular cholangiocarcinoma (HCC‐CC) and intrahepatic cholangiocarcinoma
(I‐CC) are increasingly being reported in patients with cirrhosis. The aims of this study were (…

Abbreviations: AASLD, American Association for the Study of Liver Diseases; AIH, autoimmune
hepatitis; ALP, alkaline phosphatase; ASIR, age standardized incidence rate; AST, …

Background & Aims There is limited information on the use of stereotactic body radiotherapy
(SBRT) as a bridge to liver transplantation for hepatocellular carcinoma and no study …